Acute Effects of Cannabis on Symptoms of Obsessive-Compulsive Disorder.
Dakota Mauzay, Emily M LaFrance, Carrie Cuttler
Journal of Affective Disorders January 15, 2021 DOI: 10.1016/j.jad.2020.09.124 (opens in new tab) via PubMed
Summary
AI-generated from the abstractInhaling cannabis is associated with short-term reductions in OCD symptoms. In an analysis of 1,810 cannabis use sessions tracked by 87 self-identified OCD patients via the Strainprint® app, compulsions dropped by 60%, intrusions by 49%, and anxiety by 52% from before to after inhalation. Higher CBD concentrations and higher doses predicted larger reductions in compulsions. Over 31 months, later sessions showed smaller reductions in intrusions, suggesting possible tolerance. Baseline symptom severity and dose remained stable. The absence of a placebo control and the self-selected sample limit causal conclusions.
Study at a glance
| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Sample size | 87 |
| Population | Individuals self-identifying with OCD who tracked symptoms via the Strainprint® app |
| Intervention | inhaled cannabis |
| Duration | 31 months |
| Key finding | Inhaled cannabis is associated with acute reductions in OCD symptoms, but tolerance to effects on intrusions may develop over time. |
Abstract
Little is known about the the acute effects of cannabis on symptoms of OCD in humans. Therefore, this study sought to: 1) examine whether symptoms of OCD are significantly reduced after inhaling cannabis, 2) examine predictors (gender, dose, cannabis constituents, time) of these symptom changes and 3) explore potential long-term consequences of repeatedly using cannabis to self-medicate for OCD symptoms, including changes in dose and baseline symptom severity over time. Data were analyzed from the app Strainprint® which provides medical cannabis patients a means of tracking changes in symptoms as a function of different doses and strains of cannabis across time. Specifically, data were analyzed from 87 individuals self-identifying with OCD who tracked the severity of their intrusions, compulsions, and/or anxiety immediately before and after 1,810 cannabis use sessions spanning a period of 31 months. Patients reported a 60% reduction in compulsions, a 49% reduction in intrusions, and a 52% reduction in anxiety from before to after inhaling cannabis. Higher concentrations of CBD and higher doses predicted larger reductions in compulsions. The number of cannabis use sessions across time predicted changes in intrusions, such that later cannabis use sessions were associated with smaller reductions in intrusions. Baseline symptom severity and dose remained fairly constant over time. The sample was self-selected, self-identified as having OCD, and there was no placebo control group. Inhaled cannabis appears to have short-term beneficial effects on symptoms of OCD. However, tolerance to the effects on intrusions may develop over time.